The role of baseline HIV-1 RNA, drug resistance, and regimen type as determinants of response to first-line antiretroviral therapy

scientific article published on 11 July 2014

The role of baseline HIV-1 RNA, drug resistance, and regimen type as determinants of response to first-line antiretroviral therapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/JMV.24017
P698PubMed publication ID25042976
P5875ResearchGate publication ID263858715

P50authorMaurizio ZazziQ28743821
Stefano RusconiQ40213049
Antonio Di BiagioQ41372289
Alessio SignoriQ42684924
Laura MonnoQ56487067
Andrea De LucaQ57977169
P2093author name stringBianca Bruzzone
Irene Schiavetti
Grazia Punzi
Giovanni Penco
ARCA Collaborative Group
Angela Marzocchetti
Maria Grazia Colao
P2860cites workLife expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studiesQ24597052
Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapyQ34003391
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studiesQ34139859
Comparative gender analysis of the efficacy and safety of atazanavir/ritonavir and lopinavir/ritonavir at 96 weeks in the CASTLE studyQ34481365
Sex-based outcomes of darunavir-ritonavir therapy: a single-group trialQ34664004
Clinical evaluation of Rega 8: an updated genotypic interpretation system that significantly predicts HIV-therapy responseQ34684386
Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final resultsQ35214141
Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studiesQ36285986
Web resources for HIV type 1 genotypic-resistance test interpretationQ36899999
Impact of pre-therapy viral load on virological response to modern first-line HAART.Q38427973
HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapyQ38460522
Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adultsQ39685276
Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapyQ44506169
Clinical progression of HIV-1 infection according to the viral response during the first year of antiretroviral treatment. Groupe d'Epidémiologie du SIDA en Aquitaine (GECSA).Q44962177
Sex differences in adherence to highly active antiretroviral therapy: a meta-analysisQ45024810
Efficacy and safety of rilpivirine (TMC278) versus efavirenz at 48 weeks in treatment-naive HIV-1-infected patients: pooled results from the phase 3 double-blind randomized ECHO and THRIVE TrialsQ45414505
Higher baseline levels of plasma human immunodeficiency virus type 1 RNA are associated with increased mortality after initiation of triple-drug antiretroviral therapyQ45709333
Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.Q46900196
Surrogate Markers for Disease Progression in Treated HIV InfectionQ56830875
Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts ≥ 200 cells/μlQ57259705
A Clinically Prognostic Scoring System for Patients Receiving Highly Active Antiretroviral Therapy: Results from the EuroSIDA StudyQ57877926
An Immunological Comparison of Third Companion in Advanced Drug-Naive HIV-Infected PatientsQ57997508
P433issue10
P407language of work or nameEnglishQ1860
P921main subjectdrug resistanceQ12147416
P1104number of pages8
P304page(s)1648-1655
P577publication date2014-07-11
P1433published inJournal of Medical VirologyQ15716684
P1476titleThe role of baseline HIV-1 RNA, drug resistance, and regimen type as determinants of response to first-line antiretroviral therapy
P478volume86

Reverse relations

cites work (P2860)
Q38619193Discordant responses to cART in HIV-1 patients in the era of high potency antiretroviral drugs: clinical evaluation, classification, management prospects
Q64060835INSTI-Based Triple Regimens in Treatment-Naïve HIV-Infected Patients Are Associated With HIV-RNA Viral Load Suppression at Ultralow Levels
Q51746832Predictors of retention in care in HIV-infected patients in a large hospital cohort in Italy.
Q69682379Rates and Correlates of Short Term Virologic Response among Treatment-Naïve HIV-Infected Children Initiating Antiretroviral Therapy in Ethiopia: A Multi-Center Prospective Cohort Study
Q39412054Structural equation modelling of viral tropism reveals its impact on achieving viral suppression within 6 months in treatment-naive HIV-1-infected patients after combination antiretroviral therapy
Q39648233Virological response and resistance profile in HIV-1-infected patients starting darunavir-containing regimens.

Search more.